company background image
8329 logo

Shenzhen Neptunus Interlong Bio-technique SEHK:8329 Stock Report

Last Price

HK$0.16

Market Cap

HK$268.5m

7D

15.9%

1Y

14.3%

Updated

21 Dec, 2024

Data

Company Financials

Shenzhen Neptunus Interlong Bio-technique Company Limited

SEHK:8329 Stock Report

Market Cap: HK$268.5m

8329 Stock Overview

Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. More details

8329 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Shenzhen Neptunus Interlong Bio-technique Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shenzhen Neptunus Interlong Bio-technique
Historical stock prices
Current Share PriceHK$0.16
52 Week HighHK$0.18
52 Week LowHK$0.12
Beta0.22
1 Month Change15.11%
3 Month Change9.59%
1 Year Change14.29%
3 Year Change-13.51%
5 Year Change-32.49%
Change since IPO-56.16%

Recent News & Updates

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Nov 07
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Sep 05
Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Recent updates

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Nov 07
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

Sep 05
Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings

We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

Apr 19
We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings

These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Oct 03
These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

Mar 29
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

Sep 28
We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Aug 18
A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Jun 06
Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Dec 15
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Dec 29
Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Nov 24
Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Shareholder Returns

8329HK PharmaceuticalsHK Market
7D15.9%-1.9%-0.5%
1Y14.3%-3.9%19.9%

Return vs Industry: 8329 exceeded the Hong Kong Pharmaceuticals industry which returned -3.9% over the past year.

Return vs Market: 8329 underperformed the Hong Kong Market which returned 19.9% over the past year.

Price Volatility

Is 8329's price volatile compared to industry and market?
8329 volatility
8329 Average Weekly Movement10.8%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.6%
10% least volatile stocks in HK Market4.1%

Stable Share Price: 8329 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 8329's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,471n/awww.interlong.com

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. It offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. The company is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business.

Shenzhen Neptunus Interlong Bio-technique Company Limited Fundamentals Summary

How do Shenzhen Neptunus Interlong Bio-technique's earnings and revenue compare to its market cap?
8329 fundamental statistics
Market capHK$268.48m
Earnings (TTM)HK$34.27m
Revenue (TTM)HK$1.12b

7.8x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8329 income statement (TTM)
RevenueCN¥1.05b
Cost of RevenueCN¥658.52m
Gross ProfitCN¥395.31m
Other ExpensesCN¥363.16m
EarningsCN¥32.15m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.019
Gross Margin37.51%
Net Profit Margin3.05%
Debt/Equity Ratio8.5%

How did 8329 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 23:46
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Neptunus Interlong Bio-technique Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution